A Novel and Selective Poly (ADP-Ribose) Polymerase Inhibitor Ameliorates Chemotherapy-Induced Painful Neuropathy

BACKGROUND: Chemotherapy-induced neuropathy is the principle dose limiting factor requiring discontinuation of many chemotherapeutic agents, including cisplatin and oxaliplatin. About 30 to 40% of patients receiving chemotherapy develop pain and sensory changes. Given that poly (ADP-ribose) polymera...

Descripción completa

Detalles Bibliográficos
Autores principales: Ta, Lauren E., Schmelzer, James D., Bieber, Allan J., Loprinzi, Charles L., Sieck, Gary C., Brederson, Jill D., Low, Philip A., Windebank, Anthony J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542321/
https://www.ncbi.nlm.nih.gov/pubmed/23326593
http://dx.doi.org/10.1371/journal.pone.0054161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542321/
https://www.ncbi.nlm.nih.gov/pubmed/23326593
http://dx.doi.org/10.1371/journal.pone.0054161

Ejemplares similares